Cystic fibrosis (CF) is a dubious disease in the field of infectious respiratory digestive and endocrine disorders. Clinical performance is complex and often involves multi-system fatigue. Early identification and standardised clinical care are essential for improving prognosis.
The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation. The platform can help to align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of cystic fibrosis (CF) requires individualized development of treatment programs, typically including multidimensional management such as drug therapy, rehabilitation intervention, regular follow-up.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored during the treatment process, and timely adjusted according to the changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of cystic fibrosis CF.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.